Hengxu Capital

Hengxu Capital is a market-oriented private equity firm with a strong industrial background, established in 2019. The firm's equity investment team strategically focuses on sectors aligned with China's economic transformation and new quality productive forces, specifically targeting technology, healthcare, and consumer sectors. Additionally, its alternative investment team is dedicated to merger-and-acquisition opportunities in high-quality new energy infrastructure assets, including wind power, photovoltaics, energy storage, and charging, aiming to deliver sustainable and stable returns for investors while promoting environmental, social, and governance (ESG) aspects.

Founded in 2019, Hengxu Capital was established as a market-oriented private equity company. It is noted as a private equity investment subsidiary of SAIC Motor. The firm's inception aimed to leverage its industrial background to identify and invest in opportunities that contribute to China's economic transformation and foster new quality productive forces.

Hengxu Capital boasts a diverse portfolio of investments across its target sectors. Notable portfolio companies include Aibo Medical, which successfully completed an IPO. Other investments span various high-tech and healthcare fields, such as Beijing Jingpin Tezhuan Technology Co., Ltd. (optoelectronic reconnaissance equipment and military robot systems), Jiangsu Tongxingbao Smart Transportation Technology Co., Ltd. (smart transportation solutions), Asiainfo Security Technology Co., Ltd. (cybersecurity software), Zhejiang Laoying Semiconductor Technology Co., Ltd. (new semiconductor materials), Shanghai Xinwang Microelectronics Technology Co., Ltd. (MCU & DSP products), Qingtao (Kunshan) Energy Development Co., Ltd. (solid-state lithium batteries), Jiangsu Yahong Pharmaceutical Technology Co., Ltd. (urogenital system oncology), Shanghai Meiliweiye Medical Technology Co., Ltd. (interventional devices for chronic diseases), and Demei United (Chongqing) Medical Technology Co., Ltd. (sports medicine implants and equipment).

The firm's management team comprises seasoned professionals from diverse fields, bringing extensive industry expertise and exceptional investment capabilities to deliver outstanding and sustainable fund performance. The core team has a long-standing collaboration, working together for over ten years, and includes top-level professionals from first-class institutions. This collective experience, coupled with a self-driven, diligent, and responsible attitude, underpins Hengxu Capital's efficient and compliant execution capabilities. Lu Yongtao, the Chairman, previously oversaw SAIC Motor's IPO and capital operations, accumulating an AUM exceeding 66 billion RMB across SAIC Capital and Hengxu Capital, and incubating over 20 listed companies.